Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a serious liver disorder associated with the accumulation of fat and inflammation. The objective of this study was to determine the gut microbiota composition that might influence the progression of NAFLD. Germ-free mice were inoculated with feces from patients with nonalcoholic steatohepatitis (NASH) or from healthy persons (HL) and then fed a standard diet (STD) or high-fat diet (HFD). We found that the epididymal fat weight, hepatic steatosis, multifocal necrosis, and inflammatory cell infiltration significantly increased in the NASH-HFD group. These findings were consistent with markedly elevated serum levels of alanine transaminase, aspartate transaminase, endotoxin, interleukin 6 (IL-6), monocyte chemotactic protein 1 (Mcp1), and hepatic triglycerides. In addition, the mRNA expression levels of Toll-like receptor 2 (Tlr2), Toll-like receptor 4 (Tlr4), tumor necrosis factor alpha (Tnf-α), Mcp1, and peroxisome proliferator-activated receptor gamma (Ppar-γ) significantly increased. Only abundant lipid accumulation and a few inflammatory reactions were observed in group HL-HFD. Relative abundance of Bacteroidetes and Firmicutes shifted in the HFD-fed mice. Furthermore, the relative abundance of Streptococcaceae was the highest in group NASH-HFD. Nevertheless, obesity-related Lactobacillaceae were significantly upregulated in HL-HFD mice. Our results revealed that the gut microbiota from NASH Patients aggravated hepatic steatosis and inflammation. These findings might partially explain the NAFLD progress distinctly was related to different compositions of gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To establish causality, transplantation of fecal microbiota from patients with MASLD or MASH induced steatosis and fibrosis in antibiotic-treated and germ-free mice (87, 202, 203).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [203]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Hence, colonization of GF mice with the “obesity-related microbiota” resulted in a significant increase in total body fat relative to GF mice colonized with a “thinness-related microbiota” [22].”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“Research has shown that the relative abundance of Bacteroidetes is lower and that of Firmicutes is higher in obese mice compared to their leaner counterparts [26].”
BackgroundGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“Follow-up experiments involving human fecal samples from twins discordant for obesity (when transplanted into gnotobiotic mice) showed significant body composition differences [15].”
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 3×
“The level of Bacteroidetes is significantly lower in obese subjects as compared with normal-weight subjects [13].”
BackgroundThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · cited 5×
“Several animal models have revealed that TLR deficiency-associated changes in the gut microbiota composition are related to exacerbated hepatic steatosis and inflammation [2].”
BackgroundInfluentialInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
The role of gut microbiota in immune homeostasis and autoimmunity
Wu, H.-J., & Wu, E. (2012) · Gut Microbes · doi:10.4161/gmic.19320 · Cited by 1,426
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Genes and Molecules of Lactobacilli Supporting Probiotic Action
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00017-08 · Cited by 1,013 · cited 1×
“Lactobacillus is lactic acid bacteria that can suppress pathogens, enhance epithelial barrier function, and modulate immune responses [56]: actions that seem to protect from the pathogenesis of NAFLD and/or NASH.”
BackgroundIntestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303816 · Cited by 1,001
Levy, M., Thaiss, C. A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J. A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.048 · Cited by 960
Goodman, A. L., Kallstrom, G., Faith, J. J., Reyes, A., Moore, A., Dantas, G., & Gordon, J. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102938108 · Cited by 777
Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · cited 1×
“Other studies that compared obese patients with healthy controls uncovered an increase in cell counts of genus Lactobacillus and a decrease in the family Ruminococcaceae in obese patients [54,55].”
ResultJiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep08096 · Cited by 649
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Liang, W., Menke, A. L., Driessen, A., Koek, G. H., Lindeman, J. H., Stoop, R., Havekes, L. M., Kleemann, R., & van den Hoek, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115922 · Cited by 577
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
Membrez, M., Blancher, F., Jaquet, M., Bibiloni, R., Cani, P. D., Burcelin, R. G., Corthesy, I., Macé, K., & Chou, C. J. (2008) · The FASEB Journal · doi:10.1096/fj.07-102723 · Cited by 493 · cited 1×
“Membrez and coworkers used ob/ob mice to show that modulation of the gut microbiota via antibiotics reduces hepatic steatosis and improves glucose sensitivity [46].”
BackgroundInfluence of high-fat diet on gut microbiota: a driving force for chronic disease risk
Murphy, E. A., Velazquez, K. T., & Herbert, K. M. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000209 · Cited by 492
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
Hirota, S. A., Ng, J., Lueng, A., Khajah, M., Parhar, K., Li, Y., Lam, V., Potentier, M. S., Ng, K., Bawa, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21478 · Cited by 431
Self-citationEvolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 376
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Braunersreuther, V. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i8.727 · Cited by 362
Wong, V. W.-S., Tse, C.-H., Lam, T. T.-Y., Wong, G. L.-H., Chim, A. M.-L., Chu, W. C.-W., Yeung, D. K.-W., Law, P. T.-W., Kwan, H.-S., Yu, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062885 · Cited by 342
Gut microflora as a target for energy and metabolic homeostasis
Cani, P. D., & Delzenne, N. M. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282efdebb · Cited by 332 · cited 6×
“Several research groups demonstrated a correlation between type 2 diabetes and obesity [20,45].”
BackgroundInfluentialToll-like receptors as targets in chronic liver diseases
Mencin, A., Kluwe, J., & Schwabe, R. F. (2009) · Gut · doi:10.1136/gut.2008.156307 · Cited by 329
Gäbele, E., Dostert, K., Hofmann, C., Wiest, R., Schölmerich, J., Hellerbrand, C., & Obermeier, F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.035 · Cited by 324
Verma, S., Jensen, D., Hart, J., & Mohanty, S. R. (2013) · Liver International · doi:10.1111/liv.12226 · Cited by 314
Gut bacterial microbiota and obesity
Million, M., Lagier, J.-C., Yahav, D., & Paul, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12172 · Cited by 287
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
De Minicis, S., Rychlicki, C., Agostinelli, L., Saccomanno, S., Candelaresi, C., Trozzi, L., Mingarelli, E., Facinelli, B., Magi, G., Palmieri, C., et al. (2014) · Hepatology · doi:10.1002/hep.26695 · Cited by 279
Prada, P. O., Zecchin, H. G., Gasparetti, A. L., Torsoni, M. A., Ueno, M., Hirata, A. E., Corezola do Amaral, M. E., Höer, N. F., Boschero, A. C., & Saad, M. J. A. (2005) · Endocrinology · doi:10.1210/en.2004-0767 · Cited by 244
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
Cryer, P. E. (2012) · Endocrinology · doi:10.1210/en.2011-1499 · Cited by 242 · cited 1×
“Cryer reported that an increase in serum glucose concentration induces an increase in insulin secretion by β-cells of the pancreas; however, β-cell failure did not result in a decrease in β-cell insulin secretion [47].”
BackgroundProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236 · cited 2×
“Several recent studies have used germ-free mice that were colonized by a human gut microflora to investigate the disease progression of inflammatory bowel disease (IBD) colitis [11] and intestinal physiology [12].”
BackgroundYe, D., Li, F. Y. L., Lam, K. S. L., Li, H., Jia, W., Wang, Y., Man, K., Lo, C. M., Li, X., & Xu, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300269 · Cited by 206 · cited 1×
“Furthermore, Ye and colleagues demonstrated that Tlr4 is essential for hepatic fat deposition and NASH development [42].”
BackgroundDi Luccia, B., Crescenzo, R., Mazzoli, A., Cigliano, L., Venditti, P., Walser, J.-C., Widmer, A., Baccigalupi, L., Ricca, E., & Iossa, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134893 · Cited by 177
Sheng, L., Jena, P. K., Liu, H.-X., Kalanetra, K. M., Gonzalez, F. J., French, S. W., Krishnan, V. V., Mills, D. A., & Wan, Y.-J. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01576-9 · Cited by 155
Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice
Ellekilde, M., Selfjord, E., Larsen, C. S., Jakesevic, M., Rune, I., Tranberg, B., Vogensen, F. K., Nielsen, D. S., Bahl, M. I., Licht, T. R., et al. (2014) · Scientific Reports · doi:10.1038/srep05922 · Cited by 153
Ganz, M., Bukong, T. N., Csak, T., Saha, B., Park, J.-K., Ambade, A., Kodys, K., & Szabo, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0552-7 · Cited by 144
Elshaghabee, F. M. F., Bockelmann, W., Meske, D., de Vrese, M., Walte, H.-G., Schrezenmeir, J., & Heller, K. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00047 · Cited by 142
Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease
Toshikuni, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8393 · Cited by 140
Jena, P. K., Sheng, L., Liu, H., Kalanetra, K. M., Mirsoian, A., Murphy, W. J., French, S. W., Krishnan, V. V., Mills, D. A., & Wan, Y. Y. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.019 · Cited by 115
Inflammasomes of the intestinal epithelium
Sellin, M. E., Maslowski, K. M., Maloy, K. J., & Hardt, W. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.002 · Cited by 100
IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
Mas, E., Danjoux, M., Garcia, V., Carpentier, S., Ségui, B., & Levade, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007929 · Cited by 89
Role of gut microbiota: Obesity and NAFLD
Gangarapu, V., Yildiz, K., Tuzun Ince, A., & Baysal, B. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.7886 · Cited by 69
Du, Z., Hudcovic, T., Mrazek, J., Kozakova, H., Srutkova, D., Schwarzer, M., Tlaskalova-Hogenova, H., Kostovcik, M., & Kverka, M. (2015) · Gut Pathogens · doi:10.1186/s13099-015-0080-2 · Cited by 54
Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression
Ferreira, D. F., Fiamoncini, J., Prist, I. H., Ariga, S. K., de Souza, H. P., & de Lima, T. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.07.002 · Cited by 47
Lu, L., Yu, Y., Guo, Y., Wang, Y., Chang, E. B., & Claud, E. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124504 · Cited by 43
Itoh, K., & MITSUOKA, T. (1980) · PubMed · Cited by 43
Comparison of fecal flora of mice based upon different strains and different housing conditions.
Itoh, K., MITSUOKA, T., Sudo, K., & Suzuki, K. (1983) · PubMed · Cited by 42
Al-Jashamy, K. A., Murad, A., Zeehaida, M., Mohamad, R., & Jaafar, H. (2010) · PubMed · Cited by 40
The Microbiome and Cancer: Implications for Oncology Nursing Science
Kelly, D. L., Lyon, D., Yoon, S. L., & Horgas, A. L. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000286 · Cited by 32
Development of gut microflora in obese and lean rats
Šefčíková, Z., Kmeť, V., Bujňáková, D., Raček, Ľ., & Mozeš, Š. (2010) · Folia Microbiologica · doi:10.1007/s12223-010-0061-2 · Cited by 23
Satoh, H., Ide, N., Kagawa, Y., & Maeda, T. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-01000 · Cited by 14
Establishment of Specific Pathogen-Free (SPF) Rat Colonies using Gnotobiotic Techniques.
YANABE, M., SHIBUYA, M., GONDA, T., Asai, H., Tanaka, T., SUDOU, K., NARITA, T., & Itoh, K. (2001) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.50.293 · Cited by 14
Cited by
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Mouries, J., Brescia, P., Silvestri, A., Spadoni, I., Sorribas, M., Wiest, R., Mileti, E., Galbiati, M., Invernizzi, P., Adorini, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.005 · Cited by 688
Walter, J., Armet, A. M., Finlay, B. B., & Shanahan, F. (2020) · Cell · doi:10.1016/j.cell.2019.12.025 · Cited by 596
The role of the microbiome in NAFLD and NASH
Kolodziejczyk, A. A., Zheng, D., Shibolet, O., & Elinav, E. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809302 · Cited by 523
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354
Metadata
- Authors
- Chiu, C.-C., Ching, Y.-H., Li, Y.-P., Liu, J.-Y., Huang, Y.-T., Huang, Y.-W., Yang, S.-S., Huang, W.-C., & Chuang, H.-L.
- Affiliations
- Agricultural Technology Research Institute (TW)
- Tzu Chi University (TW)
- National Chung Hsing University (TW)
- National Institutes of Applied Research (TW)
- Cathay General Hospital (TW)
- National Taipei University of Nursing and Health Science (TW)
- Corresponding author
- Huang, Wen-Ching
- Chuang, Hsiao-Li
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-11-06
- Volume
- 9
- Issue
- 11
- Pages
- 1220
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5707692
- OpenAlex
- W2765713881
- Cited by
- 160
- References
- 59
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 18 · 2023: 24 · 2022: 21 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 10
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology (MOST) of Taiwan (MOST 106-2319-B-492-001, NSC 100-2320-B-492-001-, NSC 101-2320-B-492-001-MY3, MOST 106-2410-H-227-007-)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, high-fat diet, gnotobiotic mice, fecal microbiota transplantation, hepatic steatosis, liver inflammation, Toll-like receptors, Bacteroidetes, Firmicutes, Streptococcaceae, Lactobacillaceae, endotoxin, interleukin-6, MCP-1, TNF-α, PPARγ
- MeSH terms
- Gastrointestinal Microbiome, Adipose Tissue, Animals, Germ-Free Life, Humans, Liver, Male, Mice, Inbred C57BL, Mice, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.